ORIGINAL RESEARCH
Accepted on 06 Feb 2025
MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis
doi 10.3389/fphar.2025.1551863
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Advancing Glioma Treatment: Novel Drugs, Mechanisms of Resistance, and Therapeutic Strategies
Advancing Glioma Treatment: Novel Drugs, Mechanisms of Resistance, and Therapeutic Strategies
853
Total downloads
3,981
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
GENERAL COMMENTARY
Published on 12 Dec 2024
General commentary: GQIcombi application to subdue glioma via differentiation therapy
doi 10.3389/fonc.2024.1466102
- 289 views
ORIGINAL RESEARCH
Published on 24 Oct 2024
Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
doi 10.3389/fphar.2024.1485067
- 709 views
ORIGINAL RESEARCH
Published on 22 Oct 2024
PACAP38 synergizes with irradiation to suppress the proliferation of multiple cancer cells via regulating SOX6/Wnt/β-catenin signaling
doi 10.3389/fphar.2024.1492453
- 807 views
ORIGINAL RESEARCH
Published on 10 Oct 2024
CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome
doi 10.3389/fphar.2024.1479480
- 427 views
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 3,981Topic views
- 2,052Article views
- 853Article downloads